Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI115640

Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?

D Récan, P Chafey, F Leturcq, J P Hugnot, N Vincent, F Tomé, H Collin, D Simon, P Czernichow, and L V Nicholson

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Récan, D. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Chafey, P. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Leturcq, F. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Hugnot, J. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Vincent, N. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Tomé, F. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Collin, H. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Simon, D. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Czernichow, P. in: JCI | PubMed | Google Scholar

Institut National de la Santé et de la Recherche Médicale (INSERM) U129, Institut Cochin de Génétique Moléculaire, Paris, France.

Find articles by Nicholson, L. in: JCI | PubMed | Google Scholar

Published February 1, 1992 - More info

Published in Volume 89, Issue 2 on February 1, 1992
J Clin Invest. 1992;89(2):712–716. https://doi.org/10.1172/JCI115640.
© 1992 The American Society for Clinical Investigation
Published February 1, 1992 - Version history
View PDF
Abstract

It has been hypothesized that the tight localization of dystrophin at the muscle membrane is carried out by its cysteine-rich and/or carboxyl domains. We report the results of biochemical and immunocytochemical investigations of dystrophin in muscle from a 1-yr-old patient with a large deletion that removes the distal part of the dystrophin gene, thus spanning the exons coding for the cysteine-rich and the carboxy-terminal domains, and extends beyond the glycerol kinase and congenital adrenal hypoplasia genes. Immunological analysis of muscle dystrophin shows that the deletion results in the production of a truncated, but stable, polypeptide correctly localized at the sarcolemma. These data indicate that neither the cysteine-rich domain, nor the carboxyl domain, are necessary for the appearance of normal dystrophin sarcolemmal localization.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 712
page 712
icon of scanned page 713
page 713
icon of scanned page 714
page 714
icon of scanned page 715
page 715
icon of scanned page 716
page 716
Version history
  • Version 1 (February 1, 1992): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts